SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-125427
Filing Date
2024-11-12
Accepted
2024-11-12 16:15:25
Documents
66
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q olma-20240930.htm   iXBRL 10-Q 2521364
2 EX-31.1 olma-ex31_1.htm EX-31.1 15151
3 EX-31.2 olma-ex31_2.htm EX-31.2 15172
4 EX-32.1 olma-ex32_1.htm EX-32.1 11868
  Complete submission text file 0000950170-24-125427.txt   8969622

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT olma-20240930.xsd EX-101.SCH 1084720
68 EXTRACTED XBRL INSTANCE DOCUMENT olma-20240930_htm.xml XML 1634519
Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39712 | Film No.: 241448378
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)